Yang et al., 2019 [11] demonstrated the role of m6A-eraser protein ‘FTO’ in melanoma progression, a type of skin cancer, and enlightened the intrinsic mechanism to improve the efficacy of anti-PD-1 therapy by targeting FTO. This evidence concerns the gene FTO and skin cancer.